BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30919984)

  • 21. Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec.
    Zakaria AS; Santos F; Kassouf W; Tanguay S; Aprikian A
    Urol Int; 2016; 97(1):49-53. PubMed ID: 26863611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restrictive transfusion in radical cystectomy is safe.
    Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S
    Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer.
    Ripping TM; Witjes JA; Meijer RP; van Rhijn BWG; Oddens JR; Goossens-Laan CA; Mulder SF; van Moorselaar RJA; Kiemeney LA; Aben KKH
    Urol Oncol; 2020 Dec; 38(12):935.e9-935.e16. PubMed ID: 32917503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy.
    Bhindi B; Yu J; Kuk C; Sridhar SS; Hamilton RJ; Finelli A; Jewett MA; Evans A; Fleshner NE; Zlotta AR; Kulkarni GS
    J Urol; 2014 Sep; 192(3):714-9. PubMed ID: 24594406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
    Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
    Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
    Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
    World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes.
    Khanna A; Saarela O; Lawson K; Finelli A; Haber GP; Lee B; Abouassaly R
    J Urol; 2019 Sep; 202(3):490-497. PubMed ID: 31009290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base.
    Smith AB; Deal AM; Woods ME; Wallen EM; Pruthi RS; Chen RC; Milowsky MI; Nielsen ME
    BJU Int; 2014 Nov; 114(5):719-26. PubMed ID: 24325202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA
    Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
    Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
    BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
    Sammon JD; Morgan M; Djahangirian O; Trinh QD; Sun M; Ghani KR; Jeong W; Jhaveri J; Ehlert M; Schmitges J; Bianchi M; Shariat SF; Perrotte P; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
    BJU Int; 2012 Nov; 110(9):1301-9. PubMed ID: 22449122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
    Ha YS; Kim SW; Chun SY; Chung JW; Choi SH; Lee JN; Kim BS; Kim HT; Yoo ES; Kwon TG; Kim WT; Kim WJ; Kim TH
    BMC Urol; 2019 Jan; 19(1):10. PubMed ID: 30678673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    Waingankar N; Mallin K; Smaldone M; Egleston BL; Higgins A; Winchester DP; Uzzo RG; Kutikov A
    BJU Int; 2017 Aug; 120(2):239-245. PubMed ID: 28192632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved surgical outcomes following radical cystectomy at high-volume centers influence overall survival.
    Scarberry K; Berger NG; Scarberry KB; Agrawal S; Francis JJ; Yih JM; Gonzalez CM; Abouassaly R
    Urol Oncol; 2018 Jun; 36(6):308.e11-308.e17. PubMed ID: 29628316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.
    Mason RJ; Frank I; Bhindi B; Tollefson MK; Thompson RH; Karnes RJ; Tarrell R; Thapa P; Boorjian SA
    World J Urol; 2017 Dec; 35(12):1879-1884. PubMed ID: 28913657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
    Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
    Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
    Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.